After the Czech Republic turned to Beijing for help in providing vaccines against the Chinese Communist virus, the country’s outbreak rose rather than fell, with cases of second-degree infection skyrocketing nearly tenfold.
A diagram of the vaccine from China National Pharmaceutical Corporation
On March 3, Czech presidential spokesman Ovchacek reportedly said that the Czech Republic had asked Beijing for help in providing the Sinopharm vaccine and that the Chinese side had agreed to the Czech request.
However, according to data released by the Czech National Institute of Public health (NIPH), cited by AFP on March 23, the number of secondary infections in the country was 56 at the end of 2020; by February 28, the number of secondary infections had increased to 158; and by March 23, the number of secondary infections had skyrocketed to 1,400. By March 23, the number of second-degree infections had skyrocketed to 1,400.
In other words, in the last 22 days, the number of secondary infections in the Czech Republic has increased almost tenfold. The Czech National Institute of Public Health believes that this unusual situation is related to the significant increase in the number of diagnoses during the winter.
Recent Comments